Sanctuary Advisors LLC Sells 5,310 Shares of CVS Health Co. (NYSE:CVS)

Sanctuary Advisors LLC lowered its position in shares of CVS Health Co. (NYSE:CVS) by 2.8% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 187,126 shares of the pharmacy operator’s stock after selling 5,310 shares during the period. Sanctuary Advisors LLC’s holdings in CVS Health were worth $8,400,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently modified their holdings of the company. AMF Tjanstepension AB boosted its position in CVS Health by 124.1% during the third quarter. AMF Tjanstepension AB now owns 61,744 shares of the pharmacy operator’s stock valued at $3,882,000 after buying an additional 34,198 shares during the period. Sequoia Financial Advisors LLC boosted its holdings in CVS Health by 49.2% during the 3rd quarter. Sequoia Financial Advisors LLC now owns 47,708 shares of the pharmacy operator’s stock valued at $3,000,000 after acquiring an additional 15,741 shares during the period. Waldron Private Wealth LLC grew its position in CVS Health by 9.7% during the 3rd quarter. Waldron Private Wealth LLC now owns 7,005 shares of the pharmacy operator’s stock worth $440,000 after acquiring an additional 622 shares during the last quarter. Community Trust & Investment Co. increased its stake in CVS Health by 2.2% in the 3rd quarter. Community Trust & Investment Co. now owns 259,457 shares of the pharmacy operator’s stock worth $16,315,000 after purchasing an additional 5,643 shares during the period. Finally, Albert D Mason Inc. boosted its stake in shares of CVS Health by 1.5% during the third quarter. Albert D Mason Inc. now owns 15,425 shares of the pharmacy operator’s stock valued at $970,000 after purchasing an additional 224 shares during the period. 80.66% of the stock is currently owned by hedge funds and other institutional investors.

Insider Buying and Selling

In other CVS Health news, Director Michael F. Mahoney purchased 30,000 shares of the firm’s stock in a transaction dated Tuesday, February 18th. The stock was purchased at an average price of $66.70 per share, for a total transaction of $2,001,000.00. Following the completion of the purchase, the director now directly owns 39,356 shares of the company’s stock, valued at $2,625,045.20. This trade represents a 320.65 % increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. 0.24% of the stock is owned by company insiders.

Analysts Set New Price Targets

Several brokerages recently commented on CVS. Evercore ISI lifted their target price on shares of CVS Health from $60.00 to $65.00 and gave the stock an “outperform” rating in a research note on Monday, January 27th. Edward Jones raised shares of CVS Health from a “hold” rating to a “buy” rating in a research note on Thursday, January 30th. Deutsche Bank Aktiengesellschaft raised CVS Health from a “hold” rating to a “buy” rating and set a $66.00 target price on the stock in a research note on Tuesday, December 3rd. TD Cowen upped their price target on CVS Health from $73.00 to $80.00 and gave the company a “buy” rating in a research report on Monday, November 25th. Finally, Mizuho cut their price objective on CVS Health from $73.00 to $66.00 and set an “outperform” rating on the stock in a research report on Thursday, October 24th. Four equities research analysts have rated the stock with a hold rating, seventeen have assigned a buy rating and one has issued a strong buy rating to the company. According to MarketBeat, CVS Health has a consensus rating of “Moderate Buy” and a consensus price target of $70.00.

CVS Health Stock Performance

Shares of CVS opened at $66.35 on Thursday. CVS Health Co. has a 52 week low of $43.56 and a 52 week high of $80.75. The company has a quick ratio of 0.60, a current ratio of 0.81 and a debt-to-equity ratio of 0.80. The stock has a market cap of $83.65 billion, a P/E ratio of 18.13, a P/E/G ratio of 0.98 and a beta of 0.61. The business’s 50 day moving average price is $51.80 and its 200-day moving average price is $56.12.

CVS Health (NYSE:CVS) last released its earnings results on Wednesday, February 12th. The pharmacy operator reported $1.19 EPS for the quarter, topping analysts’ consensus estimates of $0.89 by $0.30. CVS Health had a return on equity of 9.11% and a net margin of 1.24%. Equities research analysts anticipate that CVS Health Co. will post 5.92 earnings per share for the current fiscal year.

CVS Health Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Monday, February 3rd. Investors of record on Thursday, January 23rd were given a dividend of $0.665 per share. This represents a $2.66 annualized dividend and a dividend yield of 4.01%. The ex-dividend date of this dividend was Thursday, January 23rd. CVS Health’s dividend payout ratio (DPR) is currently 72.68%.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.